1360460-82-7Relevant articles and documents
Anlotinib hydrochloride intermediate and preparation method of anlotinib hydrochloride
-
, (2019/11/04)
The invention provides an anlotinib hydrochloride intermediate and a preparation method of anlotinib hydrochloride. 4-hydroxy-6-methoxyl-7-GO substituted quinolone and 2-fluorine-3-halogenate-6-bitrotoluene are used for generating 4-(2-fluorine-3-methyl-4
Method for synthesizing anlotinib and hydrochloride thereof
-
Paragraph 0033-0034; 0044-0046, (2018/12/14)
The invention relates to a method for synthesizing anlotinib and hydrochloride thereof. Specifically, the method comprises steps (1) to (3) and step (4) or (5) in the description. According to the method disclosed by the invention, a technological flow is
Quinoline derivatives and preparation method for the crystallization of the
-
Paragraph 0054-0063, (2018/02/04)
The invention relates to a crystal of a quinoline derivative, a preparation method of the crystal, a pharmaceutical composition comprising the crystal and application of the pharmaceutical composition in the field of medicine, in particular to three crystalline solid manners of quinoline derivative dihydrochloride, namely an A-type crystal, a B-type crystal and a C-type crystal, wherein the A-type crystal and the B-type crystal are crystals basically not containing crystal water molecules and other solvents, and the C-type crystal is the crystal containing two crystal water molecules.